Sources | Names Used |
---|---|
CTRPv2 | erlotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | erlotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CTC-487M23.8 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
mRNA | USP19 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
mRNA | FETUB | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
mRNA | TACC1 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
mRNA | CRACR2A | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
mRNA | ALG10B | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
mRNA | SKAP2 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.02 |
mRNA | UPP1 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.02 |
mRNA | SLC24A3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
mRNA | ZDHHC15 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |